cabozantinib
ipsen
['gu ', 'rcc,(-irccs),(-srcc),(-urcc)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'cabopoint']
wrapping up day 2 of gu with of who expanded on interim results from the cabopoint study in advanced rcc. tune in tomorrow for key updates and takeaways from the final day of the symposium! #gu23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.